v3.26.1
Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings
Treasury Stock, Common
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjustment
Total MetLife, Inc.'s Stockholders' Equity
Total MetLife, Inc.'s Stockholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interests
Beginning Balance at Dec. 31, 2024 $ 27,703 $ (1,074) $ 0 $ 12 $ 33,791 $ 42,626 $ (27,798) $ (21,186) $ (1,074) $ 27,445 $ (1,074) $ 258
Treasury stock acquired in connection with share repurchases (1,424)           (1,424)     (1,424)    
Stock-based compensation 29       29         29    
Dividends on preferred stock (66)         (66)       (66)    
Dividends on common stock (374)         (374)       (374)    
Change in equity of noncontrolling interests 1                 0   1
Net income (loss) 950         945       945   5
Other comprehensive income (loss), net of income tax 2,010             2,012   2,012   (2)
Ending Balance at Mar. 31, 2025 27,755   0 12 33,820 43,131 (29,222) (20,248)   27,493   262
Beginning Balance at Dec. 31, 2025 28,680   0 12 32,858 44,290 (30,678) (18,084)   28,398   282
Treasury stock acquired in connection with share repurchases (762)           (762)     (762)    
Stock-based compensation 63       63         63    
Dividends on preferred stock (45)         (45)       (45)    
Dividends on common stock (372)         (372)       (372)    
Change in equity of noncontrolling interests (12)                 0   (12)
Net income (loss) 1,190         1,185       1,185   5
Other comprehensive income (loss), net of income tax (1,147)             (1,143)   (1,143)   (4)
Ending Balance at Mar. 31, 2026 $ 27,595   $ 0 $ 12 $ 32,921 $ 45,058 $ (31,440) $ (19,227)   $ 27,324   $ 271